EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹94 Cr | ₹-56 Cr | ₹221 Cr | ₹134 Cr | ₹-172 Cr |
What is the latest Net Cash Inflow / Outflow ratio of EMCURE PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹94 Cr |
| Mar2025 | ₹-56 Cr |
| Mar2024 | ₹221 Cr |
| Mar2023 | ₹134 Cr |
| Mar2022 | ₹-172 Cr |
How is Net Cash Inflow / Outflow of EMCURE PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹94 Cr | Positive | |
| Mar2025 | ₹-56 Cr | Negative | |
| Mar2024 | ₹221 Cr | 64.85 | |
| Mar2023 | ₹134 Cr | Positive | |
| Mar2022 | ₹-172 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹33,779.9 Cr | 0.9% | -10.1% | 31.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.1% | -6.5% | 3.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,780.0 Cr | -0.2% | -5.5% | 35.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,828.0 Cr | 0.4% | -8.2% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,305.0 Cr | 1.7% | -2% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,759.0 Cr | 4.9% | 7.7% | -2.5% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 0.9% |
-10.1% |
31.4% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
You may also like the below Video Courses